In the pancreas, it stimulates insulin release when blood sugar is high and suppresses glucagon secretion, further aiding blood sugar control
All current findings remain pre-clinical and exploratory , with ongoing research aimed at better understanding 5-Amino-1MQs role as a research tool for metabolic and enzymatic signaling analysis
Quick Answer: Tirzepatide does not require tapering from a pharmacological perspective, as the FDA prescribing information does not mandate gradual dose reduction when stopping treatment
We need more studies to understand what using it for an extended period of time might do [12]
Kishimoto A, Imaizumi A, Wada H, Yamakage H, Satoh-Asahara N, Hashimoto T, et al
How fast do you lose weight on semaglutide vs